EQS-Adhoc

LifeWatch AG: LifeWatchTM erhält CE Zulassung für Vital Signs Monitoring

EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Regulatory Approval
LifeWatch AG: LifeWatchTM erhält CE Zulassung für Vital Signs
Monitoring

25.06.2015 / 07:00
Release of an ad hoc announcement pursuant to Art. 53 KR.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------

LifeWatch receives CE marking for continuous vital signs monitoring

Zug/Switzerland, June 25, 2015 - LifeWatch AG (SIX Swiss Exchange: LIFE), a
leading developer and provider of medical solutions and remote diagnostic
monitoring services in the digital health market, is pleased to announce
that it has received CE Marking of Conformity for its continuous Vital
Signs Monitoring Service.

The wireless, patch-based vital signs monitoring system makes vital signs
monitoring faster, easier and more convenient for both, patients and
hospital staff. It will allow for early detection of vital sign changes and
faster interventions, increased nursing efficiency and higher patient
satisfaction.

The Vital Signs Patch is an easy-to-use cable-free sensor worn on a
patient's upper chest. It is intended to be used on adult patients in a
clinical environment for the continuous, non-invasive monitoring of ECG,
heart rate, respiration rate, surface temperature, arterial blood oxygen
saturation and body position. It will be available in two versions (with
and without ECG) and is connected with an easy-to-use wireless supporting
system which provides medical information and alerts remotely to hospital
staff.

Dr. Stephan Rietiker, CEO of LifeWatch, stated: "This clearance represents
a significant technological development for LifeWatch and continues to
strengthen our position as an innovational leader in digital health. It
allows us to start the market acceptance testing for vital signs monitoring
in Europe and is a big step towards offering services for patients outside
of the US."

The results of our European market acceptance tests will support the US
launch and global roll-out.



For further questions:

LifeWatch AG
c/o Dynamics Group, Philippe Blangey / Doris Rudischhauser
Phone: [phone]
E-mail: [e-mail] About LifeWatch AG:
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE),